These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 22985791)
1. The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis. Vo DT; Subramaniam D; Remke M; Burton TL; Uren PJ; Gelfond JA; de Sousa Abreu R; Burns SC; Qiao M; Suresh U; Korshunov A; Dubuc AM; Northcott PA; Smith AD; Pfister SM; Taylor MD; Janga SC; Anant S; Vogel C; Penalva LO Am J Pathol; 2012 Nov; 181(5):1762-72. PubMed ID: 22985791 [TBL] [Abstract][Full Text] [Related]
2. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy. Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648 [TBL] [Abstract][Full Text] [Related]
3. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma. Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF Cells; 2021 Dec; 11(1):. PubMed ID: 35011618 [TBL] [Abstract][Full Text] [Related]
4. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. Vo DT; Qiao M; Smith AD; Burns SC; Brenner AJ; Penalva LO RNA Biol; 2011; 8(5):817-28. PubMed ID: 21881409 [TBL] [Abstract][Full Text] [Related]
5. The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells. Vo DT; Abdelmohsen K; Martindale JL; Qiao M; Tominaga K; Burton TL; Gelfond JA; Brenner AJ; Patel V; Trageser D; Scheffler B; Gorospe M; Penalva LO Mol Cancer Res; 2012 Jan; 10(1):143-55. PubMed ID: 22258704 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
7. Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival. Wang XY; Penalva LO; Yuan H; Linnoila RI; Lu J; Okano H; Glazer RI Mol Cancer; 2010 Aug; 9():221. PubMed ID: 20727204 [TBL] [Abstract][Full Text] [Related]
8. Genomic analyses of musashi1 downstream targets show a strong association with cancer-related processes. de Sousa Abreu R; Sanchez-Diaz PC; Vogel C; Burns SC; Ko D; Burton TL; Vo DT; Chennasamudaram S; Le SY; Shapiro BA; Penalva LO J Biol Chem; 2009 May; 284(18):12125-35. PubMed ID: 19258308 [TBL] [Abstract][Full Text] [Related]
9. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Imai T; Tokunaga A; Yoshida T; Hashimoto M; Mikoshiba K; Weinmaster G; Nakafuku M; Okano H Mol Cell Biol; 2001 Jun; 21(12):3888-900. PubMed ID: 11359897 [TBL] [Abstract][Full Text] [Related]
10. Antagonism between the RNA-binding protein Musashi1 and miR-137 and its potential impact on neurogenesis and glioblastoma development. Velasco MX; Kosti A; Guardia GDA; Santos MC; Tegge A; Qiao M; Correa BRS; Hernández G; Kokovay E; Galante PAF; Penalva LOF RNA; 2019 Jul; 25(7):768-782. PubMed ID: 31004009 [TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein Musashi1 modulates glioma cell growth through the post-transcriptional regulation of Notch and PI3 kinase/Akt signaling pathways. Muto J; Imai T; Ogawa D; Nishimoto Y; Okada Y; Mabuchi Y; Kawase T; Iwanami A; Mischel PS; Saya H; Yoshida K; Matsuzaki Y; Okano H PLoS One; 2012; 7(3):e33431. PubMed ID: 22428049 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma. Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617 [TBL] [Abstract][Full Text] [Related]
14. The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. Nikpour P; Baygi ME; Steinhoff C; Hader C; Luca AC; Mowla SJ; Schulz WA J Cell Mol Med; 2011 May; 15(5):1210-24. PubMed ID: 20477901 [TBL] [Abstract][Full Text] [Related]
15. Msi1 promotes tumor growth and cell proliferation by targeting cell cycle checkpoint proteins p21, p27 and p53 in cervical carcinomas. Liu X; Yang WT; Zheng PS Oncotarget; 2014 Nov; 5(21):10870-85. PubMed ID: 25362645 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-31 suppresses medulloblastoma cell growth by inhibiting DNA replication through minichromosome maintenance 2. Jin Y; Xiong A; Zhang Z; Li S; Huang H; Yu TT; Cao X; Cheng SY Oncotarget; 2014 Jul; 5(13):4821-33. PubMed ID: 24970811 [TBL] [Abstract][Full Text] [Related]
17. FOXG1 expression shows correlation with neuronal differentiation in cerebellar development, aggressive phenotype in medulloblastomas, and survival in a xenograft model of medulloblastoma. Adesina AM; Veo BL; Courteau G; Mehta V; Wu X; Pang K; Liu Z; Li XN; Peters L Hum Pathol; 2015 Dec; 46(12):1859-71. PubMed ID: 26433703 [TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. Yi C; Li G; Ivanov DN; Wang Z; Velasco MX; Hernández G; Kaundal S; Villarreal J; Gupta YK; Qiao M; Hubert CG; Hart MJ; Penalva LOF RNA Biol; 2018; 15(11):1420-1432. PubMed ID: 30362859 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of MUSASHI1 in epithelial breast cancer cells is due to down regulation of miR-125b. Forouzanfar M; Lachinani L; Dormiani K; Nasr-Esfahani MH; Ghaedi K BMC Mol Cell Biol; 2021 Feb; 22(1):10. PubMed ID: 33541259 [TBL] [Abstract][Full Text] [Related]
20. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]